129 related articles for article (PubMed ID: 9723699)
1. Promoter-associated displacement of hypermutations.
Wu P; Claflin L
Int Immunol; 1998 Aug; 10(8):1131-8. PubMed ID: 9723699
[TBL] [Abstract][Full Text] [Related]
2. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
Lin MM; Green NS; Zhang W; Scharff MD
Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
[TBL] [Abstract][Full Text] [Related]
3. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.
Betz AG; Milstein C; González-Fernández A; Pannell R; Larson T; Neuberger MS
Cell; 1994 Apr; 77(2):239-48. PubMed ID: 8168132
[TBL] [Abstract][Full Text] [Related]
4. Insertion of 2 kb of bacteriophage DNA between an immunoglobulin promoter and leader exon stops somatic hypermutation in a kappa transgene.
Winter DB; Sattar N; Mai JJ; Gearhart PJ
Mol Immunol; 1997 Apr; 34(5):359-66. PubMed ID: 9293769
[TBL] [Abstract][Full Text] [Related]
5. Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes.
Umar A; Schweitzer PA; Levy NS; Gearhart JD; Gearhart PJ
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4902-6. PubMed ID: 1905016
[TBL] [Abstract][Full Text] [Related]
6. The 5' boundary of somatic hypermutation in a V kappa gene is in the leader intron.
Rada C; González-Fernández A; Jarvis JM; Milstein C
Eur J Immunol; 1994 Jun; 24(6):1453-7. PubMed ID: 8206104
[TBL] [Abstract][Full Text] [Related]
7. Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes.
González-Fernández A; Milstein C
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9862-6. PubMed ID: 8234326
[TBL] [Abstract][Full Text] [Related]
8. High-level rearrangement and transcription of yeast artificial chromosome-based mouse Ig kappa transgenes containing distal regions of the contig.
Li S; Hammer RE; George-Raizen JB; Meyers KC; Garrard WT
J Immunol; 2000 Jan; 164(2):812-24. PubMed ID: 10623827
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
Tumas-Brundage KM; Vora KA; Manser T
Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
[TBL] [Abstract][Full Text] [Related]
10. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.
Kong Q; Zhao L; Subbaiah S; Maizels N
J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236
[TBL] [Abstract][Full Text] [Related]
11. Strand bias in Ig somatic hypermutation is determined by signal sequence within the variable region.
Ching AK; Li PS; Chan WY; Ma CH; Lee SS; Lim PL; Chui YL
Int Immunol; 2000 Sep; 12(9):1245-53. PubMed ID: 10967019
[TBL] [Abstract][Full Text] [Related]
12. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.
Rogerson BJ
Mol Immunol; 1994 Feb; 31(2):83-98. PubMed ID: 8309480
[TBL] [Abstract][Full Text] [Related]
13. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.
Lebecque SG; Gearhart PJ
J Exp Med; 1990 Dec; 172(6):1717-27. PubMed ID: 2258702
[TBL] [Abstract][Full Text] [Related]
14. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.
Weber JS; Berry J; Manser T; Claflin JL
J Immunol; 1991 May; 146(10):3652-5. PubMed ID: 1902859
[TBL] [Abstract][Full Text] [Related]
15. Dual enigma of somatic hypermutation of immunoglobulin variable genes: targeting and mechanism.
Winter DB; Gearhart PJ
Immunol Rev; 1998 Apr; 162():89-96. PubMed ID: 9602355
[TBL] [Abstract][Full Text] [Related]
16. Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.
O'Brien RL; Brinster RL; Storb U
Nature; 1987 Mar 26-Apr 1; 326(6111):405-9. PubMed ID: 3104790
[TBL] [Abstract][Full Text] [Related]
17. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
18. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
19. Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutation.
Cannell PK; Amlot P; Attard M; Hoffbrand AV; Foroni L
Leukemia; 1994 Jul; 8(7):1139-45. PubMed ID: 8035605
[TBL] [Abstract][Full Text] [Related]
20. Defining the nucleic acid substrate for somatic hypermutation.
Steele EJ; Rothenfluh HS; Both GW
Immunol Cell Biol; 1992 Apr; 70 ( Pt 2)():129-44. PubMed ID: 1398773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
